Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?

To: FNS who wrote (688)	5/29/1998 12:19:00 AM
From: David S.	Respond to of 965

CYPB does not have a drug for RA. enjoy your cola

To: FNS who wrote (688)	5/29/1998 8:16:00 AM
From: PawPr	Respond to of 965

ReoPro appears to be much more effective than Integrilin; in fact, I was surprised the latter got FDA approval. I think they knew they'd have to low ball the price to have any chance of selling it. BT

To: FNS who wrote (688)	5/29/1998 11:58:00 AM
From: PawPr	Read Replies (1) \| Respond to of 965

Whoops! Stopped out @ 40. Since I had bought in @ 39 1/2 last week I placed a stop this AM to protect against the unexpected, and today's drop was certainly unexpected, at least by me. I'm kind of sorry I'm out, because I think CNTO will trade up a bit over the next few weeks, after the "buy on the rumor, sell on the news" people are gone. However, I think Mr. Hecht must be smoking the good stuff to think it'll reach 70 anytime in the foreseeable future. Stick with CYPB; also look into IMII. And DON'T GIVE UP ON THE DRILLERS! BT